STOCK TITAN

Yatsen Announces First Quarter 2026 Financial Results

(Neutral)
Tags

Yatsen (NYSE:YSG) reported unaudited Q1 2026 results with total net revenues up 22.5% to RMB1.02 billion, driven by a 58.5% increase in Skincare Brands to RMB574.2 million (56.2% of revenue). Gross margin rose to 80.2%, but net loss widened to RMB61.9 million and non-GAAP results turned to a loss. Operating expenses rose 32.5%, mainly from higher selling and marketing and R&D spending. Cash, restricted cash and short-term investments declined to RMB934.2 million, with RMB90.0 million operating cash outflow. The company completed a first closing of a ~US$120 million private placement of convertible notes and warrants and guided Q2 2026 revenue to RMB1.20–1.30 billion, implying 10%–20% year-over-year growth.

Loading...
Loading translation...

Positive

  • Q1 2026 net revenues up 22.5% year over year to RMB1.02 billion
  • Skincare Brands revenue up 58.5% to RMB574.2 million, 56.2% of total
  • Gross margin increased to 80.2% from 79.1% year over year
  • Combined Galénic, DR.WU and Eve Lom revenues up 61.4% year over year
  • Q2 2026 revenue guidance RMB1.20–1.30 billion, +10%–20% YoY
  • First closing of ~US$120 million convertible notes and warrants private placement

Negative

  • Q1 2026 net loss widened to RMB61.9 million; net loss margin 6.1%
  • Non-GAAP result shifted to RMB57.3 million net loss from prior-year income
  • Total operating expenses rose 32.5% to RMB918.1 million, 89.9% of revenue
  • Selling and marketing expenses increased to RMB737.2 million, 72.2% of revenue
  • Net cash used in operating activities was RMB90.0 million versus prior-year inflow
  • Cash, restricted cash and short-term investments fell to RMB934.2 million from RMB1.05 billion

News Market Reaction – YSG

+3.86%
7 alerts
+3.86% Session close to close
+21.5% Peak Tracked
-2.9% Trough Tracked
$275.96M Market Cap
0.7x Rel. Volume

In the May 26 session, YSG gained 3.86%, reflecting a moderate positive market reaction. Argus tracked a peak move of +21.5% during that session. Argus tracked a trough of -2.9% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Q1 2026 revenue growth of 22.5% to RMB1.02 billion, driven by Skincare ...
Analysis

This announcement highlights Q1 2026 revenue growth of 22.5% to RMB1.02 billion, driven by Skincare Brands rising to 56.2% of sales and gross margin improving to 80.2%. At the same time, net loss expanded to RMB61.9 million and operating cash outflow reached RMB90.0 million, underscoring ongoing profitability challenges. Historically, earnings have produced mixed share-price reactions, so investors may watch whether Q2 revenue guidance of RMB1.20–1.30 billion is achieved alongside tighter expense control.

Key Figures

Total net revenues: RMB1.02 billion (US$148.0 million) Skincare Brands revenue: RMB574.2 million (US$83.2 million) Gross margin: 80.2% +5 more
8 metrics
Total net revenues RMB1.02 billion (US$148.0 million) Q1 2026, up 22.5% YoY from RMB833.5 million
Skincare Brands revenue RMB574.2 million (US$83.2 million) Q1 2026, up 58.5% YoY from RMB362.4 million
Gross margin 80.2% Q1 2026, up from 79.1% prior-year quarter
Net loss RMB61.9 million (US$9.0 million) Q1 2026, vs RMB5.6 million prior-year quarter
Non-GAAP net loss RMB57.3 million (US$8.3 million) Q1 2026, vs non-GAAP net income RMB7.1 million prior-year
Cash & short-term investments RMB934.2 million (US$135.4 million) Balance as of March 31, 2026
Operating cash flow RMB90.0 million used (US$13.0 million) Q1 2026, vs RMB23.8 million generated prior-year
Q2 2026 revenue guidance RMB1.20–1.30 billion Guided YoY increase of approximately 10%–20%

Previous Earnings Reports

5 past events · Latest: Mar 02 (Positive)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Mar 02 FY 2025 earnings Positive -9.0% Reported 2025 revenue growth, margin gains and sharply narrowed net loss.
Nov 17 Q3 2025 earnings Positive -20.3% Strong Q3 2025 revenue and skincare growth with improved gross margin.
Aug 21 Q2 2025 earnings Positive +0.6% Q2 2025 delivered 36.8% revenue growth and a swing to non-GAAP profit.
Feb 25 FY 2024 earnings Neutral -4.6% Mixed FY 2024 with margin gains but goodwill impairment-driven net loss.
Nov 20 Q3 2024 earnings Neutral +11.4% Q3 2024 revenue decline but improved gross margin and narrowed net loss.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings releases often brought volatility, with several prior quarters seeing share price declines despite revenue growth and margin improvement.

Recent Company History

Over recent earnings cycles, Yatsen reported consistent revenue growth and expanding gross margins, led by Skincare Brands becoming a larger share of sales. However, prior earnings on Nov 17, 2025 and Mar 2, 2026 saw negative price reactions of -20.32% and -8.99% despite operational progress. Earlier quarters showed narrowing net losses and occasional non-GAAP profitability. Today’s Q1 2026 results continue the topline growth and margin gains theme but with a widened loss, against a backdrop of historically mixed market responses.

Key Terms

non-gaap, convertible notes, warrants, ads, +4 more
8 terms
non-gaap financial
"Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million..."
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
View in glossary
convertible notes financial
"private placement of convertible notes and warrants in an aggregate principal amount..."
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
warrants financial
"private placement of convertible notes and warrants in an aggregate principal amount..."
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
View in glossary
ads financial
"Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter..."
Ads are paid promotional messages a company places across media — online, on TV, in print, or on social platforms — to attract customers, explain products, or shape public perception. For investors, ads matter because they drive sales growth, affect how much a company must spend to win customers, and influence brand strength and long-term value. Ads can also create regulatory or reputational risk if claims are misleading, which can affect profits and stock price.
american depositary shares financial
"ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
private placement financial
"we completed the first closing of our private placement of convertible notes..."
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
net income margin financial
"Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9%..."
Net income margin measures the portion of a company’s sales that remains as profit after paying all costs, interest, and taxes, expressed as a percentage of revenue. It matters to investors because it shows how much profit a business keeps from each dollar of sales—like the slice of a pie left after all the bills are paid—helping compare profitability across companies and track whether management is improving efficiency or facing pressure on margins.
operating loss margin financial
"Operating loss margin was 9.7%, as compared with 4.1% for the prior year period."
Operating loss margin is the percentage of a company’s sales that is lost on core business activities after paying everyday operating costs, calculated as operating loss divided by revenue. Think of a store that sells $100 of goods but spends $10 more than it earns on rent, wages and supplies—the operating loss margin tells you that core operations are losing 10% of sales; investors watch it to judge whether the business model and cost structure are sustainable and improving.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026

GUANGZHOU, China, May 26, 2026 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.

First Quarter 2026 Highlights

  • Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period.
  • Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period.
  • Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.
  • Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period.

Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."

First Quarter 2026 Financial Results

Net Revenues

Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]

Gross Profit and Gross Margin

Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.

Operating Expenses

Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.

  • Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency.
  • Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform.
  • General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat.
  • Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.

Loss / Income from Operations

Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.

Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.

Net Loss / Income

Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.

Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.

Balance Sheet and Cash Flow

As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.

Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.

Business Outlook

For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.

Exchange Rate

This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.

[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.

[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.

[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.

[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.

[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.

Conference Call Information

The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong, SAR (toll free):

800-905-945

Hong Kong, SAR:

+852-3018-4992

The replay will be accessible through Tuesday, June 2, by dialing the following numbers:

United States:






+1-855-669-9658

International:






+1-412-317-0088

Replay Access Code:






4359154

A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.

For more information, please visit http://ir.yatsenglobal.com.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.

Safe Harbor Statement

This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(All amounts in thousands, except for share, per share data or otherwise noted)




December 31,



March 31,



March 31,



2025



2026



2026



RMB'000



RMB'000



USD'000

Assets









Current assets









Cash and cash equivalents



765,379




876,144




127,014

Restricted Cash



42,117




58,036




8,413

Short-term investments



246,008




-




-

Accounts receivable, net



220,870




183,701




26,631

Inventories, net



508,730




573,339




83,117

Prepayments and other current assets



450,970




440,103




63,802

Amounts due from related parties



114




53




8

Total current assets



2,234,188




2,131,376




308,985

Non-current assets









Investments



653,560




667,995




96,839

Property and equipment, net



77,014




71,982




10,435

Goodwill, net



155,029




155,029




22,474

Intangible assets, net



537,509




509,249




73,826

Deferred tax assets



1,435




1,040




151

Right-of-use assets, net



173,915




158,718




23,009

Other non-current assets



14,332




22,151




3,211

Total non-current assets



1,612,794




1,586,164




229,945

Total assets



3,846,982




3,717,540




538,930

Liabilities, redeemable non-controlling interests and shareholders'
equity









Current liabilities









Accounts and notes payable



149,371




154,805




22,442

Advances from customers



28,821




29,480




4,274

Accrued expenses and other liabilities



348,700




322,994




46,824

Amounts due to related parties



21,262




19,412




2,814

Income tax payables



13,690




13,778




1,997

Lease liabilities due within one year



53,435




53,039




7,689

Total current liabilities



615,279




593,508




86,040

Non-current liabilities









Deferred tax liabilities



107,906




106,052




15,374

Lease liabilities



123,157




110,184




15,973

Total non-current liabilities



231,063




216,236




31,347

Total liabilities



846,342




809,744




117,387

Redeemable non-controlling interests



1,337




1,337




194

Shareholders' equity









Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)



173




173




25

Treasury shares



(1,250,678)




(1,253,378)




(181,702)

Additional paid-in capital



12,296,367




12,297,001




1,782,691

Statutory reserve



31,527




31,527




4,570

Accumulated deficit



(8,141,545)




(8,202,059)




(1,189,049)

Accumulated other comprehensive income



74,760




45,910




6,657

Total Yatsen Holding Limited shareholders' equity



3,010,604




2,919,174




423,192

Non-controlling interests



(11,301)




(12,715)




(1,843)

Total shareholders' equity



2,999,303




2,906,459




421,349

Total liabilities, redeemable non-controlling interests and
shareholders' equity



3,846,982




3,717,540




538,930

 

 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(All amounts in thousands, except for share, per share data or otherwise noted)




For the Three Months Ended March 31,



2025



2026



2026



RMB'000



RMB'000



USD'000

Total net revenues



833,533




1,020,986




148,012

Total cost of revenues



(174,406)




(201,797)




(29,254)

Gross profit



659,127




819,189




118,758

Operating expenses:









Fulfilment expenses



(51,843)




(61,138)




(8,863)

Selling and marketing expenses



(553,815)




(737,236)




(106,877)

General and administrative expenses



(64,883)




(80,326)




(11,645)

Research and development expenses



(22,637)




(39,440)




(5,718)

Total operating expenses



(693,178)




(918,140)




(133,103)

Loss from operations



(34,051)




(98,951)




(14,345)

Financial income



10,606




10,741




1,557

Foreign currency exchange gain (loss)



10,664




(3,198)




(464)

Income from equity method investments, net



2,505




12,389




1,796

Other income, net



4,242




18,466




2,677

Loss before income tax expenses



(6,034)




(60,553)




(8,779)

Income tax benefits (expenses)



433




(1,375)




(199)

Net loss



(5,601)




(61,928)




(8,978)

Net loss attributable to non-controlling interests and redeemable non-
controlling interests



298




1,414




205

Net loss attributable to Yatsen's shareholders



(5,303)




(60,514)




(8,773)

Shares used in calculating loss per share (1):









Weighted average number of Class A and Class B ordinary shares:









    Basic



1,837,466,068




1,876,901,662




1,876,901,662

    Diluted



1,837,466,068




1,876,901,662




1,876,901,662

Net loss per Class A and Class B ordinary share









    Basic



(0.00)




(0.03)




(0.00)

    Diluted



(0.00)




(0.03)




(0.00)

Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)









    Basic



(0.06)




(0.64)




(0.09)

    Diluted



(0.06)




(0.64)




(0.09)

 

 



For the Three Months Ended March 31,



2025



2026



2026

Share-based compensation expenses are included in the
operating expenses as follows:


RMB'000



RMB'000



USD'000

Fulfilment expenses



98




249




36

Selling and marketing expenses



757




148




21

General and administrative expenses



7,731




2,003




290

Research and development expenses



40




1,159




168

Total



8,626




3,559




515


(1)  Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.

 

 

YATSEN HOLDING LIMITED

UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS

(All amounts in thousands, except for share, per share data or otherwise noted)




For the Three Months Ended March 31,



2025



2026



2026



RMB'000



RMB'000



USD'000

Loss from operations



(34,051)




(98,951)




(14,345)

Share-based compensation expenses



8,626




3,559




515

Amortization of intangible assets resulting from assets and business
acquisitions



10,561




10,759




1,560

Non-GAAP loss from operations



(14,864)




(84,633)




(12,270)

Net loss



(5,601)




(61,928)




(8,978)

Share-based compensation expenses



8,626




3,559




515

Amortization of intangible assets resulting from assets and business
acquisitions



10,561




10,759




1,560

Revaluation of investments on the share of equity method
investments



(6,010)




(10,469)




(1,518)

Tax effects on non-GAAP adjustments



(433)




829




120

Non-GAAP net income (loss)



7,143




(57,250)




(8,301)

Net loss attributable to Yatsen's shareholders



(5,303)




(60,514)




(8,773)

Share-based compensation expenses



8,626




3,559




515

Amortization of intangible assets resulting from assets and business
acquisitions



10,179




10,473




1,518

Revaluation of investments on the share of equity method
investments



(6,010)




(10,469)




(1,518)

Tax effects on non-GAAP adjustments



(405)




829




120

Non-GAAP net income (loss) attributable to Yatsen's
shareholders



7,087




(56,122)




(8,138)

Shares used in calculating loss per share:









Weighted average number of Class A and Class B ordinary shares:









    Basic



1,837,466,068




1,876,901,662




1,876,901,662

    Diluted



1,953,491,427




1,876,901,662




1,876,901,662

Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share









    Basic



0.00




(0.03)




(0.00)

    Diluted



0.00




(0.03)




(0.00)

Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)









    Basic



0.08




(0.60)




(0.09)

    Diluted



0.07




(0.60)




(0.09)

 

Cision View original content:https://www.prnewswire.com/news-releases/yatsen-announces-first-quarter-2026-financial-results-302781575.html

SOURCE Yatsen Holding Limited

FAQ

How did Yatsen (NYSE:YSG) perform in its Q1 2026 financial results?

Yatsen reported Q1 2026 revenue of RMB1.02 billion, up 22.5% year over year. According to Yatsen, gross margin improved to 80.2%, but the company recorded a net loss of RMB61.9 million and non-GAAP net loss of RMB57.3 million.

How did Yatsen's Skincare Brands segment perform in Q1 2026?

Yatsen’s Skincare Brands revenue rose 58.5% year over year to RMB574.2 million in Q1 2026. According to Yatsen, skincare accounted for 56.2% of total net revenues, and combined Galénic, DR.WU and Eve Lom revenue increased 61.4% compared with the prior-year period.

What was Yatsen's net loss and operating performance in Q1 2026?

Yatsen posted a Q1 2026 net loss of RMB61.9 million, with a 6.1% net loss margin. According to Yatsen, loss from operations was RMB99.0 million, and non-GAAP operating loss was RMB84.6 million, reflecting higher operating expenses versus the prior year.

What revenue guidance did Yatsen provide for Q2 2026 (YSG stock)?

Yatsen expects Q2 2026 net revenues between RMB1.20 billion and RMB1.30 billion, implying 10%–20% year-over-year growth. According to Yatsen, this outlook reflects current views on market and operational conditions and may change with future developments.

What is the size and purpose of Yatsen's 2026 private placement of convertible notes?

Yatsen completed the first closing of a private placement of convertible notes and warrants totaling about US$120 million. According to Yatsen, investors include Trustar Capital, Hillhouse and the CEO, supporting the company’s strategic direction and future business development.

What was Yatsen's cash position and cash flow in Q1 2026?

Yatsen ended March 31, 2026 with RMB934.2 million in cash, restricted cash and short-term investments. According to Yatsen, net cash used in operating activities was RMB90.0 million, compared with net operating cash inflow of RMB23.8 million a year earlier.

When is Yatsen's Q1 2026 earnings conference call and how can investors join?

Yatsen scheduled its Q1 2026 earnings conference call for May 26, 2026 at 7:30 A.M. U.S. Eastern Time. According to Yatsen, investors can dial regional numbers provided or access a live and archived webcast via the company’s investor relations website.